Retatrutide (5mg)

Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G). Among its predecessors, Semaglutide (Ozempic, Rybelsus, Wegovy) and Tirzepatide (Mounjaro), Retartrutide is also a GLP-1/GIP and Glucagon/GLP-1 dual receptor co-agonist. What does this mean?? It’s more potent than either Semaglutide or Tirzepatide with the addition of a pronounced appetite suppressing component feeling It’s the best of them all….

What does this mean in the real world?? Retatrutide is administered subcutaneously, with a half-life of 6 days, and therefore can be injected 1 x weekly. After 48 weeks, Retatrutide achieved 24.2% weight loss in obese or overweight patients and produced 17% weight loss in diabetic patients, making it arguably the most powerful 3G in the pipeline today. In addition, Retatrutide also achieved up to 86% reduction in liver fat in patients with NASH (non-alcoholic steatohepatitis). Quite simply, being overweight is now a choice – just 1 shot a week to make all the fat just melt away…

3,500

Before Placing Your Order:

Please read our FAQ to understand more about the ordering process.

Sample Dosing Schedule:

Serious Warning: Please dose this product responsibly. If you're new to the product, or haven't taken it in some time, you need to start small. Skipping to a high dose too soon will cause incredibly unpleasant & long-lasting side effects. Most users will not need to progress through to the highest dosage level to achieve substantial results.

Week 1 through 4 2.5mg per week Initial onboarding dose
Week 5 through 8 5mg per week Dose Escalation (if needed)
Week 9 through 12 7.5mg per week Dose Escalation (if needed)
Week 13 through 16 10mg per week Dose Escalation (if needed)
Week 17 through 20 12.5mg per week Dose Escalation (if needed)
Week 21+ 15mg per week Maximum indicated dose

Sterile/ bacteriostatic water sold separately

EACH VIAL CONTAINS:
Retatrutide BP 5mg

 

Reviews

There are no reviews yet.

Be the first to review “Retatrutide (5mg)”